The current trending themes include LAG-3 inhibitor (#0), neck cancer (#1), advanced melanoma (#4), T cell (#8), and renal clear cell carcinoma (#10), and it is expected that they will remain popular in the future. The gene discussed is LAG3; the disease is melanoma.